2026 News & Press Release Applied BioCode Reports Record Financial Results for the First Half of 2026; Revenue Increases 81% Year Over Year, Driven by Strong U.S. Molecular Diagnostics Growth 08/10/2026 For the six months ended June 30, 2026, the Company reported consolidated revenue of $13.59 million, an 81% increase from … Read More
2026 News & Press Release Applied BioCode Announces FDA Clearance for KingFisher™ Nucleic Acid Extraction with BioCode® Respiratory Pathogen Panel for IVD Use 05/04/2026 Read More
